Newly recruited human monocytes have a preserved responsiveness towards bacterial peptides in terms of CD11b up-regulation and intracellular hydrogen peroxide production.
The transmigration of peripheral human monocytes to the interstitium is a fundamental step in the host-defence mechanism against infections. Little is known about the state of function of in vivo transmigrated interstitial monocytes prior to differentiation into macrophages and dendritic cells. We hypothesized that newly recruited interstitial monocytes have a preserved responsiveness against bacterial-related peptides, giving them a specific role in the immediate defence against invading pathogens. In order to test this hypothesis, we explored the responsiveness of in vivo transmigrated as well as peripheral monocytes, in terms of CD11b expression and H(2)O(2) production towards the bacterial-related peptide formylmethionylleucylphenylalanine (fMLP) by the use of a skin chamber technique. In addition, we analysed the concentration of interleukin (IL)-8, monocyte chemotactic protein-1 (MCP-1) and tumour necrosis factor (TNF)-alpha in the skin blister exudates and in the circulation. We demonstrate that in vivo-transmigrated monocytes had a fivefold higher CD11b expression compared to monocytes obtained from the peripheral circulation. fMLP exposure induced a significantly higher CD11b expression on transmigrated cells compared to peripheral monocytes. In addition, newly recruited monocytes had a preserved H(2)O(2) production. The interstitial concentration of IL-8, MCP-1 and TNF-alpha was significantly higher in blister exudates compared to that in the peripheral circulation. Thus, in vivo transmigrated human monocytes preserve their capacity to respond towards bacterial peptides in terms of CD11b up-regulation and H(2)O(2) generation. These data strengthen a role for newly recruited interstitial human monocytes in the immediate defence against invading pathogens.
Dadfar
E
E
Department of Medicine, Clinical Immunology and Allergy Unit, Karolinska Institutet, Karolinska University Hospital, Sweden. elham.dadfar@ki.se
Jacobson
S H
SH
Lundahl
J
J
D000942:Antigens, Bacterial / Q000276:immunology*; D001768:Blister / Q000276:immunology; D039481:CD11b Antigen / Q000378:metabolism*; D002630:Chemotactic Factors / Q000378:metabolism; D002634:Chemotaxis, Leukocyte / Q000276:immunology; D015194:Diffusion Chambers, Culture; D005122:Exudates and Transudates / Q000276:immunology; D006801:Humans; D006861:Hydrogen Peroxide / Q000378:metabolism*; D007958:Leukocyte Count; D008875:Middle Aged; D009000:Monocytes / Q000276:immunology*; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000276:immunology; D016897:Respiratory Burst / Q000276:immunology; D012867:Skin / Q000276:immunology; D015854:Up-Regulation / Q000276:immunology*
D000942:Antigens, Bacterial; D039481:CD11b Antigen; D002630:Chemotactic Factors; D009240:N-Formylmethionine Leucyl-Phenylalanine; D006861:Hydrogen Peroxide